MHC class II Tetramer Guided Detection of Mycobacterium tuberculosis-specific CD4+ T Cells in Peripheral Blood from Patients with Pulmonary Tuberculosis.

Novel diagnostic tools are needed to diagnose latent infection and to provide biologically meaningful surrogate markers to define cellular immune responses against Mycobacterium tuberculosis (MTB). Interferon gamma-based assays have recently been developed in addition to the more than 100-year-old tuberculin skin test (TST) for the immune diagnosis of MTB in blood. The advent of soluble MHC/peptide tetramer molecules allows to objectively enumerate antigen-specific T cells. We identified novel MHC class II-restricted MTB epitopes and used HLA-DR4 tetrameric complexes to visualize ex vivo CD4⁺ T cells directed against the antigens Ag85B and the 19-kDa lipoprotein, shared between MTB and other Mycobacterium species, and CD4⁺ T cells which recognize the MTB-associated ESAT-6 antigen. MTB-reactive CD4⁺ T cells reside predominantly in the CD45RA⁺ CD28⁺ and CD45⁻ CD28⁺ T-cell subset and recognize naturally processed and presented MTB epitopes. HLA-DR4-restricted, Ag85B or ESAT-6-specific CD4⁺ T cells show similar dynamics over time in peripheral blood mononuclear cells (PBMC) when compared with CD8⁺ T cells directed against the corresponding HLA-A2-presented MTB epitopes in patients with pulmonary MTB infection and subsequent successful therapy. This was not found to be true for T-cell responses directed against the 19-kDa lipoprotein. The dissection of the cellular immune response in M. tuberculosis infection will enable novel strategies for monitoring MTB vaccine candidates and to gauge CD4⁺ T cells directed against MTB. [ABSTRACT FROM AUTHOR]